Template:Paracentesis if coagulopathic: Difference between revisions
(Created page with "===Paracentesis if coagulopathic=== *Coagulation studies are NOT required before performance of the procedure<ref>Wilkerson, Ann...") |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
===[[Procedures in patients with coagulopathies|Paracentesis if coagulopathic]]=== | ===[[Procedures in patients with coagulopathies|Paracentesis if coagulopathic]]=== | ||
*Coagulation studies are NOT required before performance of the procedure<ref>Wilkerson, Annals of Emerg Med, 2009</ref> | *Coagulation studies are NOT required before performance of the procedure<ref>Wilkerson, Annals of Emerg Med, 2009</ref> | ||
* | **Incidence of clinically significant bleeding complications is low even if in liver failure with an elevated INR (< 0.2%)<ref>Thomsen TW. Paracentesis. N Engl J Med 2006; 355: e21</ref> | ||
* | *No data supports cutoff values beyond which paracentesis should be avoided/prophylactically transfused | ||
*Routine use of [[FFP]] and [[platelets]] is not recommended | |||
*Procedure is contraindicated if the patient is actively bleeding or in [[DIC]] | |||
Latest revision as of 10:43, 3 April 2016
Paracentesis if coagulopathic
- Coagulation studies are NOT required before performance of the procedure[1]
- Incidence of clinically significant bleeding complications is low even if in liver failure with an elevated INR (< 0.2%)[2]
- No data supports cutoff values beyond which paracentesis should be avoided/prophylactically transfused
- Routine use of FFP and platelets is not recommended
- Procedure is contraindicated if the patient is actively bleeding or in DIC